Insights - Page 44 of 107 - LucidQuest Ventures

Rare Disease Today—November 13, 2025

November 13, 2025ucb,BioPharma and Tech News,Stargardt Disease,Beta Thalassemia,MHRA,Rare Disease News,AAV Gene Therapy,Rare disease regulation,TK2 deficiency,Usher syndrome type 1Bprimary biliary cholangitis,Mirum Pharmaceuticals

This week’s rare disease update spotlights key regulatory milestones,…

by LucidQuest

Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs

November 13, 2025CNS,Regulatory,rare disease,biopharma,Lucid Diligence Brief,payer access,diligence,partnerships,clinical translation,lysosomal storage disorders,BBB deliveryenzyme replacement

Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…

by Timos Papagatsias

Immunology Today—November 12, 2025

November 12, 2025pfizer,sanofi,Atopic Dermatitis,BioPharma and Tech News,autoimmune diseases,IgA Nephropathy,Immunology News,Dupixent,Allergic fungal rhinosinusitis,Chronic hand eczemaHypereosinophilic syndrome,JAK inhibitors

This week’s immunology update spotlights key developments, regulatory…

by LucidQuest

ESMO AI 2025 Preview: What to Watch in Oncology and AI

November 12, 2025Our Insights,cancerOncology AI,digital pathology,Conference Previews,esmo ai 2025,radiomics,epro,treatment response prediction,immunotherapy biomarkers,multi-omic models,trial matching,mdt decisions,digital oncology

ESMO AI at a glance Get ready for ESMO AI and Digital Oncology 2025…

by LucidQuest

Women’s Health Video Recap—November 12, 2025

November 12, 2025Koning,Elahere,FDA,breast cancer detection,breast cancer,Vera Breast CT,BioPharma and Tech News,hysterectomy,Ovarian Cancer,Hormone Therapy,Gilead,WHO,menopause,Women's Health News,Trodelvy,IARC,Together Women’s HealthWOMEN Obstetrics & Gynecology,Nestlé

This biweekly women’s health video brings you the latest breakthroughs in…

by LucidQuest

Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment

November 12, 2025digital health,clinical trials,market access,Regulatory,AI in healthcare,biopharma,RWD,Lucid Diligence Brief,payer access,HTA,expanded accesscompassionate use

Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…

by Timos Papagatsias

Neuroscience Video Recap—November 12, 2025

November 12, 2025Neurocrine Biosciences,gefurulimab,multiple sclerosis,Atalante X,Alzheimer's Disease,astrazeneca,roche,BioPharma and Tech News,Myasthenia Gravis,Johnson & Johnson,Caplyta,KOSELUGO,Neurofibromatosis Type 1,Neuroscience News,Major depressive disorderFenebrutinib,Wandercraft

This biweekly video recaps the latest breakthroughs in CNS therapeutics—from…

by LucidQuest

Neuroscience Today — November 12, 2025

November 12, 2025multiple sclerosis,Alzheimer's Disease,roche,BioPharma and Tech News,Parkinson's Disease,Eli Lilly,Brain Computer Interface,Neuroscience News,Major depressive disorder,AI in neurologyFenebrutinib,Robotic microsurgery

This week’s neuroscience update spotlights key developments, regulatory…

by LucidQuest

Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI

November 12, 2025clinical trials,Regulatory,AI in healthcare,biopharma,medtech,Neuromodulation,Brain Computer Interface,Lucid Diligence Brief,payer access,diligence,agentic AI,graphene devicesdata governance

Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for…

by Timos Papagatsias

Lucid Diligence Brief: Galecto acquires Damora Therapeutics

November 11, 2025Oncology,clinical trials,Regulatory,hematology,biopharma,Lucid Diligence Brief,payer access,diligence,capital markets,MPNantibody therapeutics

Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional…

by Timos Papagatsias

Obesity Video Recap—November 11, 2025

November 11, 2025Obesity News,GLP-1/GIPwegovy,Efpeglenatide,BioPharma and Tech News,Wave Life Sciences,GLP-1,iqvia,Novo Nordisk,Mounjaro,Tirzepatide,Zepbound,Eli Lilly,Ozempic,Viking Therapeutics,Orforglipron,Ascletis,Hanmi Pharmaceutical,Metsera

This biweekly obesity video recap reviews major moves shaping the obesity and…

by LucidQuest

Endocrinology Today—November 11, 2025

November 11, 2025BioPharma and Tech News,Cushings Syndromeosteoporosis,type 2 diabetes,type 1 diabetes,Orforglipron,GLP-1 receptor agonist,Endocrinology News,Fertility issues,G6PD deficiency,Diabetes prevention programs,Stem-cell diabetes therapy

This week in endocrinology: fresh clinical readouts, market-moving industry…

by LucidQuest

Minimize Uncertainty – Make Informed Decisions – Succeed